Korea S.E.
06:00:00 2024-04-29 pm EDT
5-day change
1st Jan Change
4,245
KRW
+3.16%
-1.51%
+1.68%
Feb. 08
EOFLOW Co.,Ltd. announced that it has received KRW 17 billion in funding from DB Financial Investment Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Tiger Investment Advisory Co.,Ltd., Hana Investment Banking & Securities Inc., Investment Arm
CI
2023
EOFLOW Co.,Ltd. cancelled the transaction announced on May 25, 2023
CI
EOFLOW Co.,Ltd. announced that it has received KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd.
On February 27, 2023, EOFLOW Co.,Ltd. closed the transaction.
EOFLOW Co.,Ltd. announced that it has received KRW 17 billion in funding from DB Financial Investment Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Tiger Investment Advisory Co.,Ltd., Hana Investment Banking & Securities Inc., Investment Arm
Feb. 07
CI
EOFLOW Co.,Ltd. cancelled the transaction announced on May 25, 2023
Dec. 05
CI
Medtronic Korea Holdings Co., Ltd. cancelled the acquisition of 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim.
Dec. 05
CI
US-based Medtronic Acquires EOFlow
23-05-29
MT
Eoflow to Raise 314.9 Billion Won via Shares Issuance
23-05-29
MT
Medtronic Korea Holdings Co., Ltd. agreed to acquire a 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim for approximately KRW 170 billion.
23-05-25
CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 314.903773785 billion in funding from Medtronic Korea Holdings Co., Ltd.
23-05-24
CI
Pharmeo Inc. announced that it has received KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd.
23-04-05
CI
Pharmeo Inc. announced that it expects to receive KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd.
23-04-04
CI
EOFLOW Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-22
CI
EOFLOW Co.,Ltd. announced that it has received KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd.
23-02-26
CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd.
23-02-20
CI
Pharmeo Inc. announced that it has received KRW 9.9078 billion in funding from EOFLOW Co.,Ltd.
23-02-16
CI
Pharmeo Inc. announced that it expects to receive KRW 9.9078 billion in funding from EOFLOW Co.,Ltd.
23-02-14
CI
Diabeloop and EOFLOW Co.,Ltd. Partners to Offer Wearable Aid with Smartphone App
23-01-11
CI
EOFlow Co., Ltd. Submits Application to the U.S. FDA for its Wearable Insulin Pump 'EOPatch'
22-12-27
CI
EOFLOW Co.,Ltd. and Zihipp Limited Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & Nash
21-12-28
CI
EOFLOW Co.,Ltd. announced that it has received KRW 9.2170284 billion in funding from Sinocare Inc.
21-12-26
CI
Biolinq Inc announced that it has received $100 million in funding from a group of investors
21-11-01
CI
Eoflow to Raise $120 Million From Share Sale
21-10-28
MT
Eoflow to Raise Nearly $8 Million Through Stock Offering
21-10-26
MT
EOFLOW Co.,Ltd. announced that it expects to receive KRW 9.2170284 billion in funding from Sinocare Inc.
21-10-25
CI
Biolinq Inc announced that it expects to receive funding
21-09-01
CI
EOFLOW Co.,Ltd. announced that it has received KRW 3.50004641 billion in funding from UXN Co., Ltd.
21-08-12
CI
UXN Co., Ltd. announced that it has received KRW 5.00024544 billion in funding from EOFLOW Co.,Ltd. and other investors
21-08-08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
EOFlow Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical devices. The Company's main products include wearable insulin pumps, insulin infusion regulators for blood sugar control in diabetic patients.
More about the company
1st Jan change
Capi.
+1.68% 90.99M +73.28% 12.36B -21.46% 7.83B +14.68% 7.21B +4.77% 5.97B +11.77% 5.14B +29.65% 4.43B -18.81% 3.9B -42.30% 2.2B +1.24% 2.02B
Medical Equipment
Stock Market Equities A294090 Stock
News EOFLOW Co.,Ltd. EOFLOW Co.,Ltd. announced that it has received KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd.
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
EOFLOW CO.,LTD. 
